Using a mass spec-based proteogenomic approach, the researchers identified commonalities in neoantigen presentation across mantle cell lymphoma patients.
The device uses triboelectric nanogenerators to precisely control mass spec ionization, allowing researchers to analyze a higher percentage of generated ions.
Nuclea's trustee has requested the court approve sale of its assets, which failed to sell at auction, to a firm run by Nuclea's former CEO Patrick Muraca.
Looking at 927 patients undergoing coronary angiography, the researchers identified a four-protein panel that outperformed traditional clinical measures.
These tardigrade-specific proteins form a disordered, glass-like solid structure and could be used to help transport pharmaceuticals.
Startup companies are taking on personalized medicine, CNET reports.
Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.
The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.
In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.